Mr. Miguel Martin reports

AURORA CANNABIS TO HOST SECOND QUARTER 2027 INVESTOR CONFERENCE CALL

Aurora Cannabis Inc. will host an investor conference call on Thursday, Nov. 12, 2026, at 8 a.m. Eastern Time/6 a.m. Mountain Time to discuss its financial results for the second quarter 2027. The company will report its financial results prior to market open that same morning.

Q2 fiscal 2027 financial results call, Nov. 12, 2026

Investor conference call details

Date:  Thursday, Nov. 12, 2026

Time:  8 a.m. Eastern Time/6 a.m. Mountain Time

Miguel Martin, executive chairman and chief executive officer, and Simona King, chief financial officer, will host the call and question-and-answer period.

As a reminder, shareholders are advised to reject Curaleaf's hostile bid by taking no action and not tendering their shares.

About Aurora Cannabis Inc.

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora's portfolio of trusted, leading brands includes Aurora, MedReleaf, Pedanios, IndiMed, San Raf, Tasty's and Whistler Medical Marijuana Co. With world-class good manufacturing practice-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of opening the world to cannabis.

We seek Safe Harbor.